Company Overview
- Website
- nuventra.com
- Phone
- (919) 973-0383(888) 615-5111
- Employees
- 25
- Founded in
- 2008
- Industry
- Materials/Manufacturing
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing
- SIC Codes
-
28 - Chemicals and Allied Products283 - Drugs
Financials & Stats
Revenue
$16B
Recent News & Media
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas
- Nov 19, 2024
- pmc.ncbi.nlm.nih.gov
Prolifagen Therapeutics Appoints M. Alexander Shaw, PhD, as Chief Executive Officer
- Sep 13, 2022
- biospace.com
Longtime Triangle CRO changes name following acquisitions
- May 3, 2022
- bizjournals.com
A population pharmacodynamic Markov mixed-effects model for determining remimazolam-induced sedation when co-administered with fentanyl in procedural sedation
- Mar 26, 2021
- ascpt.onlinelibrary.wiley.com
Nuventra Pharma Sciences Appoints Daniel Roy, M.H.A, as President
- Jan 5, 2021
- newswire.com
Population Pharmacokinetics of Remimazolam in Procedural Sedation With Nonhomogeneously Mixed Arterial and Venous Concentrations
- Oct 12, 2020
- ascpt.onlinelibrary.wiley.com
Who is Nuventra Pharma Sciences
Nuventra Pharma Sciences is a privately held company based in Durham, North Carolina. With 25 employees, the company generates $15.6 million in annual revenue. Nuventra Pharma Sciences specializes in providing clinical pharmacology, pharmacokinetic, and pharmacometric consulting services to pharmaceutical companies and Contract Research Organizations (CROs). Their expertise spans complex studies and analyses, aiming to simplify and clarify pharmacokinetic and pharmacometric principles for effective drug development. The company distinguishes itself through its team of industry-leading consultants with extensive experience in the field. Nuventra's flexible business structure allows for seamless integration with clients, maximizing the potential of clinical pharmacology studies and pharmacokinetic analyses to support marketing approval. For more information, visit www.nuventra.com.